Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection

Tiandan Xiang; Boyun Liang; Hua Wang; Xufeng Quan; Shengsong He; Helong Zhou; Yongwen He; Dongliang Yang; Baoju Wang; Xin Zheng

doi:10.1038/s41423-021-00795-5

Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection

Cell Mol Immunol. 2021 Dec;18(12):2679-2681. doi: 10.1038/s41423-021-00795-5. Epub 2021 Nov 15.

Authors

Tiandan Xiang^#^{1

2}, Boyun Liang^#^{1

2}, Hua Wang^#^{1

2}, Xufeng Quan^{1

2}, Shengsong He^{1

2}, Helong Zhou^{1

2}, Yongwen He^{1

2}, Dongliang Yang^{1

2}, Baoju Wang^{3

4}, Xin Zheng^{5

6}

Affiliations

¹ Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
³ Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. bjwang73@163.com.
⁴ Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China. bjwang73@163.com.
⁵ Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. xin11@hotmail.com.
⁶ Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China. xin11@hotmail.com.

^# Contributed equally.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19 Vaccines / adverse effects*
COVID-19 Vaccines / immunology*
Female
Hepatitis B, Chronic / immunology*
Humans
Immunogenicity, Vaccine*
Male
Surveys and Questionnaires
Vaccines, Inactivated / adverse effects*
Vaccines, Inactivated / immunology*

Substances

COVID-19 Vaccines
SARS-CoV-2 inactivated vaccines
Vaccines, Inactivated